Effect of Linagliptin and Voglibose on metabolic profile in patients with Type 2 Diabetes: a randomized, double-blind, placebo-controlled trial
Abstract Background Dipeptidyl peptidase 4 (DPP4) inhibitors improve glycemic control by promoting GLP1-mediated glucose-dependent insulin secretion and suppression of glucagon. Sitagliptin and vildagliptin have been shown to improve insulin sensitivity in patients with type 2 diabetes mellitus (T2D...
Sábháilte in:
Príomhchruthaitheoirí: | Girish Parthan (Údar), Shobhit Bhansali (Údar), Anura V. Kurpad (Údar), Rama Walia (Údar), Kishor Bhat (Údar), Anil Bhansali (Údar) |
---|---|
Formáid: | LEABHAR |
Foilsithe / Cruthaithe: |
BMC,
2018-07-01T00:00:00Z.
|
Ábhair: | |
Rochtain ar líne: | Connect to this object online. |
Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Míreanna comhchosúla
Míreanna comhchosúla
-
An evaluation of the hypolipidemic effect of an extract of Hibiscus Sabdariffa leaves in hyperlipidemic Indians: a double blind, placebo controlled trial
de réir: R Rajendran, et al.
Foilsithe / Cruthaithe: (2010) -
Fixed Dose Combination of Voglibose & Repaglinide in the Management of Postprandial Hyperglycemia in Indian Subjects
de réir: Arif Faruqui
Foilsithe / Cruthaithe: (2017) -
Cinnamon effects on blood pressure and metabolic profile: A double-blind, randomized, placebo-controlled trial in patients with stage 1 hypertension
de réir: Fatemeh Shirzad, et al.
Foilsithe / Cruthaithe: (2021) -
A double-blind placebo needle for acupuncture research
de réir: Takakura Nobuari, et al.
Foilsithe / Cruthaithe: (2007) -
Citrus Aurantium and caffeine complex versus placebo on biomarkers of metabolism: a double blind crossover design
de réir: Brian Kliszczewicz, et al.
Foilsithe / Cruthaithe: (2019)